Structure

Physi-Chem Properties

Molecular Weight:  302.1
Volume:  278.704
LogP:  -1.228
LogD:  -0.766
LogS:  -0.618
# Rotatable Bonds:  4
TPSA:  139.84
# H-Bond Aceptor:  8
# H-Bond Donor:  6
# Rings:  2
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.378
Synthetic Accessibility Score:  3.591
Fsp3:  0.538
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.117
MDCK Permeability:  5.601002339972183e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.092
Human Intestinal Absorption (HIA):  0.514
20% Bioavailability (F20%):  0.02
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.356
Plasma Protein Binding (PPB):  16.524511337280273%
Volume Distribution (VD):  0.475
Pgp-substrate:  68.37178802490234%

ADMET: Metabolism

CYP1A2-inhibitor:  0.068
CYP1A2-substrate:  0.043
CYP2C19-inhibitor:  0.014
CYP2C19-substrate:  0.154
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.235
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.232
CYP3A4-inhibitor:  0.007
CYP3A4-substrate:  0.028

ADMET: Excretion

Clearance (CL):  1.742
Half-life (T1/2):  0.923

ADMET: Toxicity

hERG Blockers:  0.135
Human Hepatotoxicity (H-HT):  0.028
Drug-inuced Liver Injury (DILI):  0.042
AMES Toxicity:  0.348
Rat Oral Acute Toxicity:  0.056
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.701
Carcinogencity:  0.07
Eye Corrosion:  0.004
Eye Irritation:  0.402
Respiratory Toxicity:  0.022

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC40377

Natural Product ID:  NPC40377
Common Name*:   Salirepin
IUPAC Name:   (2S,3R,4S,5S,6R)-2-[4-hydroxy-2-(hydroxymethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms:   Salirepin
Standard InCHIKey:  NPNFZOGKIFFKGT-UJPOAAIJSA-N
Standard InCHI:  InChI=1S/C13H18O8/c14-4-6-3-7(16)1-2-8(6)20-13-12(19)11(18)10(17)9(5-15)21-13/h1-3,9-19H,4-5H2/t9-,10-,11+,12-,13-/m1/s1
SMILES:  c1cc(c(cc1O)CO)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL468146
PubChem CID:   16681676
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9317 Itoa orientalis Species Salicaceae Eukaryota bark, twigs, and leaves n.a. n.a. PMID[18412396]
NPO27632 Idesia polycarpa Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[23628332]
NPO27632 Idesia polycarpa Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9317 Itoa orientalis Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens Inhibition = 29.7 % PMID[533220]
NPT520 Cell Line 3T3-L1 Mus musculus IC50 = 110300.0 nM PMID[533221]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC40377 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9597 High Similarity NPC97326
0.9444 High Similarity NPC166168
0.9421 High Similarity NPC226712
0.9231 High Similarity NPC104167
0.9225 High Similarity NPC87696
0.912 High Similarity NPC470510
0.912 High Similarity NPC12308
0.9084 High Similarity NPC475628
0.903 High Similarity NPC145319
0.9024 High Similarity NPC269242
0.8984 High Similarity NPC166040
0.8984 High Similarity NPC218003
0.8963 High Similarity NPC252169
0.8923 High Similarity NPC26080
0.8923 High Similarity NPC303422
0.8923 High Similarity NPC165686
0.8923 High Similarity NPC85799
0.8915 High Similarity NPC262606
0.8906 High Similarity NPC146540
0.8889 High Similarity NPC164599
0.8872 High Similarity NPC134260
0.8871 High Similarity NPC198734
0.8871 High Similarity NPC469412
0.8855 High Similarity NPC115022
0.8855 High Similarity NPC294166
0.8846 High Similarity NPC121376
0.8837 High Similarity NPC248355
0.8815 High Similarity NPC210192
0.879 High Similarity NPC469708
0.879 High Similarity NPC60589
0.8788 High Similarity NPC130496
0.8788 High Similarity NPC188555
0.8779 High Similarity NPC299144
0.8769 High Similarity NPC472024
0.8769 High Similarity NPC80600
0.876 High Similarity NPC302378
0.876 High Similarity NPC142319
0.875 High Similarity NPC475084
0.8722 High Similarity NPC185778
0.8722 High Similarity NPC238243
0.8722 High Similarity NPC79957
0.872 High Similarity NPC473875
0.8712 High Similarity NPC25821
0.8712 High Similarity NPC49074
0.8705 High Similarity NPC474422
0.8705 High Similarity NPC227902
0.8702 High Similarity NPC475067
0.8702 High Similarity NPC65942
0.8702 High Similarity NPC9912
0.8702 High Similarity NPC248307
0.8696 High Similarity NPC138915
0.8692 High Similarity NPC26653
0.8692 High Similarity NPC270849
0.8692 High Similarity NPC307110
0.8657 High Similarity NPC166180
0.8657 High Similarity NPC242028
0.8657 High Similarity NPC165482
0.8657 High Similarity NPC3293
0.8657 High Similarity NPC40664
0.8657 High Similarity NPC197723
0.8657 High Similarity NPC203230
0.8657 High Similarity NPC138350
0.8647 High Similarity NPC251981
0.8647 High Similarity NPC13745
0.8647 High Similarity NPC48863
0.8643 High Similarity NPC92054
0.8643 High Similarity NPC175976
0.8643 High Similarity NPC83975
0.8643 High Similarity NPC4958
0.8643 High Similarity NPC140722
0.8636 High Similarity NPC470270
0.8636 High Similarity NPC162093
0.8623 High Similarity NPC76176
0.8623 High Similarity NPC138227
0.8623 High Similarity NPC469313
0.8623 High Similarity NPC168579
0.8623 High Similarity NPC292443
0.8618 High Similarity NPC175771
0.8594 High Similarity NPC287429
0.8593 High Similarity NPC65530
0.8593 High Similarity NPC59324
0.8593 High Similarity NPC262328
0.8593 High Similarity NPC138738
0.8593 High Similarity NPC470413
0.8593 High Similarity NPC124149
0.8593 High Similarity NPC87777
0.8582 High Similarity NPC313334
0.8582 High Similarity NPC212670
0.8582 High Similarity NPC206264
0.8571 High Similarity NPC132895
0.8571 High Similarity NPC215833
0.8571 High Similarity NPC6836
0.8571 High Similarity NPC69513
0.8561 High Similarity NPC475096
0.8561 High Similarity NPC23807
0.8551 High Similarity NPC37793
0.854 High Similarity NPC469661
0.8537 High Similarity NPC301321
0.8529 High Similarity NPC98777
0.8529 High Similarity NPC212770
0.8529 High Similarity NPC183781
0.8529 High Similarity NPC472151
0.8519 High Similarity NPC186418
0.8519 High Similarity NPC164857
0.8507 High Similarity NPC107478
0.8507 High Similarity NPC35731
0.8507 High Similarity NPC470881
0.8507 High Similarity NPC476411
0.8507 High Similarity NPC187194
0.85 High Similarity NPC199928
0.85 High Similarity NPC99515
0.85 High Similarity NPC125755
0.85 High Similarity NPC190714
0.8496 Intermediate Similarity NPC252833
0.8496 Intermediate Similarity NPC269421
0.8489 Intermediate Similarity NPC232228
0.8485 Intermediate Similarity NPC474491
0.848 Intermediate Similarity NPC283616
0.8478 Intermediate Similarity NPC469559
0.8478 Intermediate Similarity NPC472353
0.8478 Intermediate Similarity NPC189115
0.8468 Intermediate Similarity NPC154256
0.8468 Intermediate Similarity NPC290470
0.8467 Intermediate Similarity NPC106944
0.8462 Intermediate Similarity NPC93619
0.8462 Intermediate Similarity NPC213197
0.8455 Intermediate Similarity NPC313193
0.8444 Intermediate Similarity NPC470236
0.844 Intermediate Similarity NPC15538
0.844 Intermediate Similarity NPC41844
0.844 Intermediate Similarity NPC473480
0.8438 Intermediate Similarity NPC476142
0.8429 Intermediate Similarity NPC161700
0.8429 Intermediate Similarity NPC277867
0.8425 Intermediate Similarity NPC475529
0.8417 Intermediate Similarity NPC473044
0.8406 Intermediate Similarity NPC89686
0.8406 Intermediate Similarity NPC257095
0.8406 Intermediate Similarity NPC186406
0.8406 Intermediate Similarity NPC273932
0.8394 Intermediate Similarity NPC100389
0.8382 Intermediate Similarity NPC37468
0.8382 Intermediate Similarity NPC103409
0.8382 Intermediate Similarity NPC469383
0.8382 Intermediate Similarity NPC199459
0.8382 Intermediate Similarity NPC52277
0.8382 Intermediate Similarity NPC177035
0.838 Intermediate Similarity NPC280945
0.838 Intermediate Similarity NPC96294
0.8372 Intermediate Similarity NPC474130
0.837 Intermediate Similarity NPC34456
0.8359 Intermediate Similarity NPC57751
0.8359 Intermediate Similarity NPC266045
0.8357 Intermediate Similarity NPC473045
0.8357 Intermediate Similarity NPC25292
0.8345 Intermediate Similarity NPC84207
0.8345 Intermediate Similarity NPC78809
0.8345 Intermediate Similarity NPC5253
0.8345 Intermediate Similarity NPC139976
0.8345 Intermediate Similarity NPC183536
0.8345 Intermediate Similarity NPC49542
0.8345 Intermediate Similarity NPC34965
0.8345 Intermediate Similarity NPC128337
0.8345 Intermediate Similarity NPC230718
0.8333 Intermediate Similarity NPC202700
0.8321 Intermediate Similarity NPC195196
0.8321 Intermediate Similarity NPC233559
0.8321 Intermediate Similarity NPC304152
0.831 Intermediate Similarity NPC213074
0.831 Intermediate Similarity NPC193473
0.831 Intermediate Similarity NPC15956
0.831 Intermediate Similarity NPC31325
0.831 Intermediate Similarity NPC224674
0.831 Intermediate Similarity NPC114505
0.831 Intermediate Similarity NPC275284
0.8309 Intermediate Similarity NPC472337
0.8309 Intermediate Similarity NPC55040
0.8308 Intermediate Similarity NPC221090
0.8306 Intermediate Similarity NPC157338
0.8298 Intermediate Similarity NPC476301
0.8298 Intermediate Similarity NPC472154
0.8298 Intermediate Similarity NPC271076
0.8298 Intermediate Similarity NPC43508
0.8295 Intermediate Similarity NPC152722
0.8295 Intermediate Similarity NPC46586
0.8295 Intermediate Similarity NPC204535
0.8288 Intermediate Similarity NPC92153
0.8288 Intermediate Similarity NPC260604
0.8288 Intermediate Similarity NPC279281
0.8288 Intermediate Similarity NPC230439
0.8288 Intermediate Similarity NPC299435
0.8288 Intermediate Similarity NPC299761
0.8286 Intermediate Similarity NPC478239
0.8286 Intermediate Similarity NPC470950
0.8286 Intermediate Similarity NPC46092
0.8286 Intermediate Similarity NPC185307
0.8273 Intermediate Similarity NPC108674
0.8271 Intermediate Similarity NPC295970
0.8264 Intermediate Similarity NPC238140
0.8264 Intermediate Similarity NPC114740

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC40377 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9421 High Similarity NPD1091 Approved
0.8582 High Similarity NPD1653 Approved
0.8222 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8222 Intermediate Similarity NPD1613 Approved
0.8033 Intermediate Similarity NPD290 Approved
0.7985 Intermediate Similarity NPD2861 Phase 2
0.7953 Intermediate Similarity NPD6671 Approved
0.7926 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD968 Approved
0.7737 Intermediate Similarity NPD3027 Phase 3
0.7669 Intermediate Similarity NPD1610 Phase 2
0.7647 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD6674 Discontinued
0.7634 Intermediate Similarity NPD1548 Phase 1
0.7622 Intermediate Similarity NPD7266 Discontinued
0.7594 Intermediate Similarity NPD3496 Discontinued
0.7576 Intermediate Similarity NPD1357 Approved
0.7556 Intermediate Similarity NPD4749 Approved
0.7554 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7536 Intermediate Similarity NPD4908 Phase 1
0.7469 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD8455 Phase 2
0.7442 Intermediate Similarity NPD7843 Approved
0.7438 Intermediate Similarity NPD7054 Approved
0.7429 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD3705 Approved
0.7405 Intermediate Similarity NPD7157 Approved
0.7402 Intermediate Similarity NPD2684 Approved
0.7397 Intermediate Similarity NPD1652 Phase 2
0.7397 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD7472 Approved
0.7391 Intermediate Similarity NPD7074 Phase 3
0.7388 Intermediate Similarity NPD1778 Approved
0.7375 Intermediate Similarity NPD3818 Discontinued
0.7365 Intermediate Similarity NPD5058 Phase 3
0.7357 Intermediate Similarity NPD4625 Phase 3
0.7346 Intermediate Similarity NPD6797 Phase 2
0.7324 Intermediate Similarity NPD4060 Phase 1
0.7301 Intermediate Similarity NPD7251 Discontinued
0.7301 Intermediate Similarity NPD6559 Discontinued
0.729 Intermediate Similarity NPD5402 Approved
0.7279 Intermediate Similarity NPD422 Phase 1
0.726 Intermediate Similarity NPD5763 Approved
0.726 Intermediate Similarity NPD5762 Approved
0.7256 Intermediate Similarity NPD7808 Phase 3
0.7246 Intermediate Similarity NPD6696 Suspended
0.7246 Intermediate Similarity NPD8651 Approved
0.7233 Intermediate Similarity NPD3787 Discontinued
0.7231 Intermediate Similarity NPD228 Approved
0.7226 Intermediate Similarity NPD2231 Phase 2
0.7226 Intermediate Similarity NPD2235 Phase 2
0.7222 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6653 Approved
0.7181 Intermediate Similarity NPD2677 Approved
0.7172 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD4538 Approved
0.7172 Intermediate Similarity NPD4536 Approved
0.7163 Intermediate Similarity NPD596 Approved
0.7163 Intermediate Similarity NPD600 Approved
0.7152 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD839 Approved
0.7133 Intermediate Similarity NPD6233 Phase 2
0.7133 Intermediate Similarity NPD840 Approved
0.7123 Intermediate Similarity NPD5588 Approved
0.7123 Intermediate Similarity NPD5960 Phase 3
0.7121 Intermediate Similarity NPD1398 Phase 1
0.7108 Intermediate Similarity NPD8312 Approved
0.7108 Intermediate Similarity NPD8313 Approved
0.7095 Intermediate Similarity NPD2424 Discontinued
0.7092 Intermediate Similarity NPD3018 Phase 2
0.7086 Intermediate Similarity NPD1774 Approved
0.7063 Intermediate Similarity NPD1048 Approved
0.7063 Intermediate Similarity NPD7199 Phase 2
0.7063 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD291 Approved
0.7055 Intermediate Similarity NPD7228 Approved
0.7055 Intermediate Similarity NPD3751 Discontinued
0.7055 Intermediate Similarity NPD7097 Phase 1
0.7051 Intermediate Similarity NPD37 Approved
0.7051 Intermediate Similarity NPD1934 Approved
0.7044 Intermediate Similarity NPD6234 Discontinued
0.7034 Intermediate Similarity NPD5124 Phase 1
0.7034 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD4380 Phase 2
0.7025 Intermediate Similarity NPD4966 Approved
0.7025 Intermediate Similarity NPD9365 Approved
0.7025 Intermediate Similarity NPD4967 Phase 2
0.7025 Intermediate Similarity NPD4965 Approved
0.7021 Intermediate Similarity NPD558 Phase 2
0.7007 Intermediate Similarity NPD5126 Approved
0.7007 Intermediate Similarity NPD5125 Phase 3
0.7007 Intermediate Similarity NPD7033 Discontinued
0.7006 Intermediate Similarity NPD2801 Approved
0.7006 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3225 Approved
0.6963 Remote Similarity NPD7340 Approved
0.6959 Remote Similarity NPD6032 Approved
0.6959 Remote Similarity NPD1551 Phase 2
0.6948 Remote Similarity NPD5403 Approved
0.6947 Remote Similarity NPD556 Approved
0.6944 Remote Similarity NPD6798 Discontinued
0.6933 Remote Similarity NPD6166 Phase 2
0.6933 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6933 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6929 Remote Similarity NPD3685 Discontinued
0.6929 Remote Similarity NPD2983 Phase 2
0.6929 Remote Similarity NPD2982 Phase 2
0.6919 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6355 Discontinued
0.6918 Remote Similarity NPD447 Suspended
0.6913 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6913 Remote Similarity NPD6005 Phase 3
0.6913 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6913 Remote Similarity NPD6002 Phase 3
0.6913 Remote Similarity NPD6004 Phase 3
0.6913 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6913 Remote Similarity NPD1375 Discontinued
0.6913 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6906 Remote Similarity NPD776 Approved
0.6906 Remote Similarity NPD1611 Approved
0.6906 Remote Similarity NPD1535 Discovery
0.6889 Remote Similarity NPD709 Approved
0.6887 Remote Similarity NPD3892 Phase 2
0.6887 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6887 Remote Similarity NPD4628 Phase 3
0.6887 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6884 Remote Similarity NPD6516 Phase 2
0.6884 Remote Similarity NPD5846 Approved
0.6875 Remote Similarity NPD3179 Approved
0.6875 Remote Similarity NPD3180 Approved
0.6875 Remote Similarity NPD7075 Discontinued
0.6871 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1549 Phase 2
0.6863 Remote Similarity NPD1511 Approved
0.6857 Remote Similarity NPD1608 Approved
0.6857 Remote Similarity NPD1481 Phase 2
0.6857 Remote Similarity NPD2981 Phase 2
0.685 Remote Similarity NPD289 Clinical (unspecified phase)
0.6849 Remote Similarity NPD1558 Phase 1
0.6849 Remote Similarity NPD2238 Phase 2
0.6846 Remote Similarity NPD6099 Approved
0.6846 Remote Similarity NPD6100 Approved
0.6846 Remote Similarity NPD2935 Discontinued
0.6842 Remote Similarity NPD6190 Approved
0.6842 Remote Similarity NPD969 Suspended
0.6831 Remote Similarity NPD1203 Approved
0.6831 Remote Similarity NPD1794 Approved
0.6828 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6828 Remote Similarity NPD7985 Registered
0.6821 Remote Similarity NPD5177 Phase 3
0.6818 Remote Similarity NPD5401 Approved
0.6812 Remote Similarity NPD5585 Approved
0.6809 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6809 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6807 Remote Similarity NPD5844 Phase 1
0.6803 Remote Similarity NPD5735 Approved
0.6803 Remote Similarity NPD4340 Discontinued
0.6794 Remote Similarity NPD1358 Approved
0.6792 Remote Similarity NPD2978 Approved
0.6792 Remote Similarity NPD2977 Approved
0.6791 Remote Similarity NPD821 Approved
0.6791 Remote Similarity NPD1138 Approved
0.6786 Remote Similarity NPD7685 Pre-registration
0.6783 Remote Similarity NPD6584 Phase 3
0.6779 Remote Similarity NPD4108 Discontinued
0.6779 Remote Similarity NPD2156 Approved
0.6779 Remote Similarity NPD2155 Approved
0.6779 Remote Similarity NPD2154 Approved
0.6776 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6774 Remote Similarity NPD1512 Approved
0.677 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6769 Remote Similarity NPD9697 Approved
0.6759 Remote Similarity NPD7095 Approved
0.6753 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6753 Remote Similarity NPD7213 Phase 3
0.6753 Remote Similarity NPD7212 Phase 2
0.675 Remote Similarity NPD3817 Phase 2
0.6744 Remote Similarity NPD6841 Approved
0.6744 Remote Similarity NPD6842 Approved
0.6744 Remote Similarity NPD6843 Phase 3
0.6741 Remote Similarity NPD5283 Phase 1
0.6739 Remote Similarity NPD1182 Approved
0.6738 Remote Similarity NPD9717 Approved
0.6726 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6721 Remote Similarity NPD9295 Approved
0.6719 Remote Similarity NPD1242 Phase 1
0.6716 Remote Similarity NPD1139 Approved
0.6716 Remote Similarity NPD1137 Approved
0.6713 Remote Similarity NPD2797 Approved
0.6712 Remote Similarity NPD1336 Approved
0.6711 Remote Similarity NPD5061 Approved
0.6711 Remote Similarity NPD5062 Approved
0.671 Remote Similarity NPD2505 Approved
0.671 Remote Similarity NPD7447 Phase 1
0.671 Remote Similarity NPD2504 Approved
0.6708 Remote Similarity NPD3882 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data